Navigation Links
PCMA Statement on New Average Manufacturer Price (AMP) Legislation
Date:9/28/2007

WASHINGTON, Sept. 28 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) released the following statement today supporting legislation introduced by Chairman Frank Pallone (D-NJ) of the House Energy and Commerce Subcommittee on Health:

"PCMA applauds the legislation introduced by Chairman Pallone earlier this week that would fix the flawed Average Manufacturer Price (AMP) final rule, mandated under the Deficit Reduction Act.

"PCMA supports the decision to remove PBM retail business rebates and discounts from inclusion in the final AMP rule. However, we remain concerned that mail-service and specialty pharmacy are still included in the definition of AMP. This definition is an inaccurate reflection of the retail class of trade price. Fixing AMP is important so that pharmacists can receive adequate reimbursements in Medicaid, ensuring consumers continued access to their community pharmacies."

PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. HIV Prevalence In Ethiopian Women Greater Than National Average
2. Average Age of Diabetics Smaller in China
3. Delhis Morbidity Rate Nearly One-sixth of National Average
4. Anti-smoking advertisements to be funded by Cigarette manufacturers
5. Chemists prepare for face-off with manufacturers
6. Clampdown On Fake Drugs Manufacturers In India – New Bill Enacte
7. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
8. Karla: healthy beer as claimed by German manufacturers
9. Imprisonment for fake “baby milk” manufacturers in Chia
10. German Manufacturers Find a Solution for DVT
11. FDA cracks the whip on manufacturers of unapproved Cold Medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: